Adaptive Biotechnologies director Katey Einterz Owen sells 9,615 shares for $249,990
ADPT•Director sale disclosed in SEC filing
- Adaptive Biotechnologies director Katey Einterz Owen sold 9,615 common shares on Aug. 26, 2026 at $26.
- Directly held stake fell to 78,639 shares following the transaction.
